Read more

March 22, 2021
12 min listen
Save

This Week's Headlines: March 15, 2021

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

This week, people with asthma not at higher risk for poor COVID-19 outcomes; adherence to asthma biologic therapy higher than inhaled corticosteroids; health care affordability, racial disparities persist in individuals with asthma, COPD; and more.

Read Healio's full coverage here:

People with asthma not at higher risk for poor COVID-19 outcomes, study finds

Adherence to asthma biologic therapy higher than inhaled corticosteroids

Health care affordability, racial disparities persist in individuals with asthma, COPD

Study supports early discharge, ambulatory rivaroxaban in low-risk pulmonary embolism

Low-risk status achieved or maintained in minority of patients on PAH combination therapy

References:

Badagliacca R, et al. Am J Respir Crit Care Med. 2021;doi:10.1164/rccm.202004-1006OC.

Barco S, et al. Eur Respir J. 2021;doi:10.1183/13993003.02368-2020.

Gaffney AW, et al. Chest. 2021;doi:10.1016/j.chest.2021.01.035.

Maddux JT, et al. Chest. 2020;doi:10.1016/j.chest.2020.10.050.

Sunjaya AP, et al. J Asthma. 2021;doi:10.1080/02770903.2021.1888116.

Sources/Disclosures

Collapse

Disclosures: Please see each study for relevant financial disclosures.